Drug Database
Back to search

Netherlands· NL-a43ae5d5cd04

Winrevair 45 mg poeder en oplosmiddel voor oplossing voor injectie

A sotatercept product containing sotatercept, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC C02KX06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedWinrevair 45 mg poeder en oplosmiddel…ATCC02KX06REGISTER NO.NL-a43ae5d5cd04PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sotaterceptAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sotatercept is registered in 11 of 19 countries.

Countries holding a registration under ATC C02KX06 (sotatercept), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search sotatercept products by name

Sotatercept · ATC C02KX06

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sotatercept costs, country by country.

Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sotatercept · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$167.27
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SOTATERCEPT
Manufacturer
Merck Sharp & Dohme B.V.
Country
Netherlands (NL)
ATC code
C02KX06
ATC class
Sotatercept
Defined daily dose
1 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/24/1850

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

121 interactions on record for sotatercept.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sotatercept against other medicinesHow interaction checks work

Sotatercept · interactions on record

121 records

121 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Sotatercept in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sotatercept products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Winrevair
  • Liechtenstein · Winrevair
  • Norway · Winrevair

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad94b722-0f2d-4bfd-ab10-13ef6675a632
GET /v1/drugs/ad94b722-0f2d-4bfd-ab10-13ef6675a632?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor oplossing voor injectie, Poeder voor oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/winrevair-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Sotatercept",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp132378",
  "excipients": [
    "CITROENZUUR 1-WATER (E 330)",
    "POLYSORBAAT 80 (E 433)",
    "SACCHAROSE",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "SOTATERCEPT"
  ],
  "leaflet_url": null,
  "authorised_at": "2024/08/22",
  "procedure_number": "EMEA/H/C/005647",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1850",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about sotatercept.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console